Week 2 Flashcards
(140 cards)
Characteristics of Diabetes
An ineffective response to insulin at the target cells → known as insulin resistance
OR
Insufficient (hyposecretion) or no release of insulin, by the Islets of Langerhans cells in the pancreas
Type 1 Diabetes (T1DM)
- A life-long chronic pancreatic disorder, similar in ways to T1DM.
- The cause of T1DM is unknown. It is widely accepted as an autoimmune disease, where the islet cells in the pancreas are destroyed. Other possible considerations are genetics and exposure to viruses and other environmental factors.
- T1DM can occur at any age but there are two main peaks for diagnosis. these are between 4-7 years old and 10-14 years old.
- There is no known way to prevent T1DM
- In the past, T1DM was known as juvenile diabetes or Insulin Dependent Diabetes Mellitus (IDDM). These terms are no longer used as was used in the past to refer to T2DM however people with T2DM can become insulin dependent as their disease progresses.
T1DM - Pathophysiology
- An autoimmune condition which triggers the immune system to destroy all the beta cells found in the Islet of Langerhans
- This leads to absolute insulin deficiency (zero production)
- The exact cause is unknown, however there is a strong link to genetic susceptibility (non-modifiable risk factor)
- Some environmental factors, such as viral exposure to mumps, rubella, coxsackievirus (Hand-Foot-Mouth), or chronic illnesses such as pancreatitis
T1DM FACTS
T1DM can be characterised by:
1. Absence or extremely ↓ insulin in bloodstream
2. ↑ Blood Glucose Levels (BGLs)
3. Insulin-sensitivity is normal (which means, if we administered insulin to this patient, their body would know what to do with it - in fact, it might even be overly sensitive since the body has been starved of insulin for some time)
4. ↓ Amylin secretion
What is Amylin?
Co-released with insulin from the beta cells in the cluster of pancreatic cells to suppress the release of glucagon
What is Glucagon?
Glucagon is released from alpha cells, a hormone that is needed to raised the blood glucose levels by breaking down glycogen
What happens when a T1DM eats food?
Oral intake (regardless of sugar content)
→ Glucose absorbed by the digestive tract and into the bloodstream
→ BGL rises which signals the pancreas to release insulin & amylin
→ T1DM Pancreas cannot produce any insulin because there are no/insufficient beta cells in the Islet of Langerhans
→ No insulin, no amylin is released which leads to excessive glucagon build-up in the bloodstream
→ BGL continues to rise to critically high levels which causes an imbalance in homeostasis
→ The metabolic alterations result in serum ↑ BGL and even ↑ Ketonaemia (ketones present in the blood)
T1DM - Clinical Manifestations
The 3 main presentations that bring our patients to their initial diagnosis of T1DM:
1. Polyphagia (increased hunger)
2. Polyuria (increased volume of urine)
3. Polydipsia (increased thirst)
NURSING MANAGEMENT-T1DM
- Maintain normoglycaemia as much as possible
- Initiate Food Chart
- Monitor conscious state
- Initiate Wound Chart, Skin Integrity Assessments and Referral to Wound Care/Stoma Nurses
Type II Diabetes (T2DM)
- Type 2 Diabetes Mellitus (T2DM) is a life-long chronic pancreatic disorder, similar in ways to T1DM.
- The main difference is that T2DM is considered a ‘silent but progressive disorder that develops over many years’ rather than being viewed as an autoimmune disorder
- T2DM represents 85-90% of all diabetic cases globally
- Although this term is no longer used, Non-Insulin Dependent Diabetes Mellitus (NIDDM) was used in the past to refer to T2DM however people with T2DM can become insulin dependent as their disease progresses.
PATHOPHYSIOLOGY- T2DM
- The exact cause is unknown, however this type of diabetes is strongly linked to non-modifiable factors like:
○ Certain Ethnicities
○ Genetic risk factors - The cause of many T2DM diabetics can be attributed to modifiable risk factors, such as:
○ Having hypertension
○ Dyslipidaemia
○ Obesity
○ Sedentary lifestyle
○ Poor diet
○ Smoking - There are two possible pathophysiological explanations which lead to the pancreas losing the capacity to secrete sufficient insulin in T2DM:
1. Insulin deficiency → relative shortage of insulin supply → persistent hyperglycaemia
2. Insulin resistance → ineffective response to insulin from target cells OR loss of insulin-sensitivity → persistent hyperglycaemia
What happens when insulin-deficient T2DM eats food?
Oral intake (regardless of sugar content)
→ Glucose absorbed by the digestive tract and into the bloodstream
→ BGL rises which signals the pancreas to release insulin & amylin
→ Insufficient insulin produced by T2DM pancreas which leads to excessive glucagon build-up in the bloodstream
→ BGL continues to rise to critically high levels which causes an imbalance in homeostasis
→ The metabolic alterations result in serum ↑ BGL and even ↑ Ketonaemia (ketones present in the blood)
What happens when insulin-resistant T2DM eats food?
Oral intake (regardless of sugar content)
→ Glucose absorbed by the digestive tract and into the bloodstream
→ BGL rises which signals the pancreas to release insulin & amylin
→ Pancreatic beta cells secrete insulin BUT target cells respond ineffectively and trigger the pancreas for more insulin
→ Excessive insulin in bloodstream → Hyperinsulinaemia
→ Overtime, chronic hyperglycaemia causes pancreatic beta cells to fatigue and ↓ their responsiveness to ↑ BGL
→ Gradually, pancreatic beta cells die from fatigue and result in a severe lack of insulin which further contributes to hyperglycaemia
→ Since the body still requires energy and the insulin and target cells no longer function, the body turns to lipids and ketosis for fuel → Ketonaemia
* The final point illustrates the pathophysiology behind ketones appearing in chronic T2DM *
T11DM-CLINICAL MANIFESTATIONS
- Chronic hyperglycaemia which is ↑ blood glucose levels (BGLs)
- There can also be alterations in the way their bodies metabolise proteins, carbohydrates, and fats
- People are often asymptomatic and do not realise they have T2DM until they experience some more extreme like a diabetic foot ulcer or even a myocardial infarction!
- This is because the actual clinical manifestations of T2DM can be mild, vague, and non-specific:
○ Fatigue
○ Recurrent infections
○ Recurrent Candida infections
(fungal yeast infections)
○ Poor wound healing
○ Vision changes like blurred
vision, cataracts, retinopathy
○ Paraesthesia (neuropathies
from nerve degeneration and
delayed conduction)
○ Peripheral neuropathy (altered
nerve sensation of the hands
and feet)
NURSING ASSESSMENTS FOR T1DM AND T2DM
- Fasting Blood Glucose Level (BGL)
○ Normal physiological range is 5.5 - 6.9 mmol/L
○ Diabetic (abnormal) range is ≥ 7.0 mmol/L
○ Blood test must be done on empty stomach and fasting state (8-12 hours) - Random BGL
○ Normal physiological range is 7.8 - 11.0 mmol/L
○ Diabetic (abnormal) range is ≥ 11.1 mmol/L
○ This blood test can be done at anytime - Oral glucose tolerance test
○ Normal physiological range is 7.8 - 11.0 mmol/L
○ Diabetic (abnormal) range is ≥ 11.1 mmol/L
○ The patient must drink a highly concentrated glucose drink, and their BGL is taken within the timeframe - Presence of serum HbA1c
○ Normal physiological range is 4.0 - 5.5% HbA1c
○ Diabetic (abnormal) range is ≥ 7.0% HbA1c
○ A relatively standard blood test to diagnose diabetes
What is HbA1c?
As glucose circulates in the blood, some of it binds to haemoglobin → resulting in HbA1c.
- The amount of HbA1c formed is directly related to the amount of glucose in the blood
- Because Red Blood Cells (RBCs) can survive for 3 - 4 months, HbA1c levels do not change rapidly
- Therefore the HbA1c level reflects the average amount of blood glucose during the last 2 - 3 months
- If patients’ average BGL ↑ → ↑ HbA1c levels meaning this patient has had uncontrolled diabetes for months!
- Another purpose to undergo HbA1c testing for patients is that it can aid treatment decisions
□ If treatment plans have been changed OR if their diabetes is considered unstable, HbA1c will be tested more frequently (3 - 4 monthly according to the RBC lifespan)
□ Otherwise, when diabetes is considered stable, HbA1c is only tested twice a year to monitor progress
□ It can be used to diagnose both T1DM and T2DM
Nursing Considerations for diabetes
- When to take BGL
- Care of wounds
- National Standard documents
- Falls risk assessment
- Skin integrity assessments
- Fluid balance chart
- Follow Medical advice regarding medication
- Documentation
- Escalate care promptly if there are any concerns or patient deterioration
Promotion and Prevention for diabetes
- Pre - post operative stages
- Critically unwell
- With infections
- Who are stressed
- Have poor understanding of their condition
- That can not self manage appropriately
- With chronic complications of DM
HYPOGLYCAEMIA causes
- Imbalance between blood glucose and insulin. For example - mismatched food intake with diabetic medications
- Reduced or poor timing intake of food
- Increased exercise
- Dehydration
- Illness
- Stress
- Medications / Drugs
- Surgery
HYPOGLYCAEMIA-Clinical Manifestations
Confusion, altered conscious state, combative and agitated state, difficulty speaking, visual disturbances, seizures, coma, death
Management of Hypoglycaemia
It is important to escalate care for hypoglycaemic patients, such as a Medical Emergency Team call or notifying the nurse. Effective treatment is crucial for reversing hypoglycemia. Adherence to hospital protocols is crucial for managing hypoglycemia, as values may differ between hospitals.
Hypoglycaemia- Conscious patient
- Administration of 15–20 grams of quick-acting carbohydrate (e.g. 150 mL of soft drink, 8–10 jelly beans, 1 tablespoon of syrup or honey, 4 teaspoons of jam, 120 mL juice, commercial glucose [per label instructions])
- Check blood glucose levels after 15 minutes
- Repetition of quick-acting carbohydrate administration after 15 minutes if no improvement in blood glucose
- Administration of additional food of longer-acting carbohydrate (e.g. slice of bread, dry biscuits) after symptoms subside
- Immediate notification of healthcare provider or emergency service (if patient outside hospital) if symptoms do not subside after two to three administrations of quick-acting carbohydrat
Hypoglycaemia- Worsening symptoms or unconscious patient
- Subcutaneous or intramuscular injection of 1 mg glucagon
- Intravenous administration of 50 mL 50% glucose
- Determine cause of hypoglycaemia (after correction of condition)
HYPERGLYCAEMIA
- Hyperglycaemia refers to high blood glucose levels.
- Results from increased hepatic glucose production and impaired glucose utilisation, reduced insulin and excess counter-regulatory hormones. Blood glucose levels are greater than 15mmol/L.